...
首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Safety of deliberate intraoperative and postoperative hypothermia for patients undergoing coronary artery surgery: a randomized trial.
【24h】

Safety of deliberate intraoperative and postoperative hypothermia for patients undergoing coronary artery surgery: a randomized trial.

机译:进行冠状动脉手术的患者在术中和术后进行体温过低的安全性:一项随机试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Hypothermia in the perioperative period is associated with adverse effects, particularly bleeding. Before termination of cardiopulmonary bypass, rewarming times and perfusion temperatures are often increased to avoid post-cardiopulmonary bypass hypothermia and the presumed complications. This practice may, however, also have adverse effects, particularly cerebral hyperthermia. We present safety outcomes from a trial in which patients undergoing coronary artery surgery were randomly assigned to normothermia or hypothermia for the entire surgical procedure. METHODS: Consenting patients over the age of 60 years presenting for a first, elective coronary artery surgery with cardiopulmonary bypass were randomly assigned to having their nasopharyngeal temperature maintained at either 37 degrees C (group N; 73 patients) or 34 degrees C (group H; 71 patients) throughout the intraoperative period, with no rewarming before arrival in the intensive care unit. All received tranexamic acid. RESULTS: There was no clinically important difference in intraoperative blood product or inotrope use. Temperatures on arrival in the intensive care unit were 36.7 degrees C +/- 0.38 degrees C and 34.3 degrees C +/- 0.38 degrees C in groups N and H, respectively. Blood loss during the first 12 postoperative hours was 596 +/- 356 mL in group N and 666 +/- 405 mL in group H (mean difference +/- 95% confidence interval, 70 +/- 126 mL; P =.28). There was no significant difference in blood product utilization, intubation time, time in the hospital, myocardial infarction, or mortality. The mean time in the intensive care unit was 8.4 hours less in the hypothermic group (P =.02). CONCLUSIONS: Our data support the safety of perioperative mild hypothermia in patients undergoing elective nonreoperative coronary artery surgery with cardiopulmonary bypass. These findings suggest that complete rewarming after hypothermic cardiopulmonary bypass is not necessary in all cases.
机译:背景:围手术期体温过低与不良反应特别是出血有关。在终止心肺转流术之前,通常会增加复温时间和灌注温度,以避免心肺转流术后体温过低和假定的并发症。但是,这种做法也可能产生不利影响,尤其是脑部高温。我们提供了一项试验的安全性结果,在该试验中,在整个外科手术过程中,将接受冠状动脉手术的患者随机分配至正常体温或体温过低。方法:将同意首次行选择性体外循环冠状动脉外科手术的60岁以上患者,其鼻咽温度维持在37摄氏度(N组; 73例患者)或34摄氏度(H组) ; 71名患者)在整个术中期间,到达重症监护室之前没有复温。全部接受氨甲环酸。结果:术中血液制品或药物的使用没有临床上的重要差异。 N组和H组到达重症监护室时的温度分别为36.7摄氏度+/- 0.38摄氏度和34.3摄氏度+/- 0.38摄氏度。术后第一个12个小时的失血量在N组为596 +/- 356 mL,在H组为666 +/- 405 mL(平均差异+/- 95%置信区间,70 +/- 126 mL; P = .28 )。血液制品利用率,插管时间,住院时间,心肌梗塞或死亡率没有显着差异。在低温治疗组中,重症监护室的平均时间减少了8.4小时(P = .02)。结论:我们的数据支持接受选择性非手术性冠状动脉搭桥手术的围手术期亚低温的安全性。这些发现表明,在所有情况下,低温体外循环后均无需完全复温。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号